These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27358808)

  • 1. Yield of intensified tuberculosis case-finding activities using Xpert(®) MTB/RIF among risk groups in Nepal.
    Khanal S; Baral S; Shrestha P; Puri M; Kandel S; Lamichanne B; Elsey H; Brouwer M; Goel S; Chinnakali P
    Public Health Action; 2016 Jun; 6(2):136-41. PubMed ID: 27358808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extending 'Contact Tracing' into the Community within a 50-Metre Radius of an Index Tuberculosis Patient Using Xpert MTB/RIF in Urban, Pakistan: Did It Increase Case Detection?
    Fatima R; Qadeer E; Yaqoob A; Haq MU; Majumdar SS; Shewade HD; Stevens R; Creswell J; Mahmood N; Kumar AM
    PLoS One; 2016; 11(11):e0165813. PubMed ID: 27898665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Community-Based Systematic Screening of Household Contacts of Patients with Multidrug-Resistant Tuberculosis in Myanmar.
    Kyaw NTT; Sithu A; Satyanarayana S; Kumar AMV; Thein S; Thi AM; Wai PP; Lin YN; Kyaw KWY; Tun MMT; Oo MM; Aung ST; Harries AD
    Trop Med Infect Dis; 2019 Dec; 5(1):. PubMed ID: 31881646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensified tuberculosis case finding among HIV-infected persons using a WHO symptom screen and Xpert(®) MTB/RIF.
    Adelman MW; Tsegaye M; Kempker RR; Alebachew T; Haile K; Tesfaye A; Aseffa A; Blumberg HM
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1197-203. PubMed ID: 26459533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
    Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
    BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the yield of systematic screening for tuberculosis among three priority groups in Ho Chi Minh City, Viet Nam.
    Vo LNQ; Codlin AJ; Forse RJ; Nguyen NT; Vu TN; Le GT; Van Truong V; Do GC; Dang HM; Nguyen LH; Nguyen HB; Nguyen NV; Levy J; Lonnroth K; Squire SB; Caws M
    Infect Dis Poverty; 2020 Dec; 9(1):166. PubMed ID: 33292638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing Tuberculosis Diagnostic Yield in Smear/Culture and Xpert® MTB/RIF-Based Algorithms Using a Non-Randomised Stepped-Wedge Design.
    Naidoo P; Dunbar R; Lombard C; du Toit E; Caldwell J; Detjen A; Squire SB; Enarson DA; Beyers N
    PLoS One; 2016; 11(3):e0150487. PubMed ID: 26930400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost Analysis of Tuberculosis Diagnosis in Cambodia with and without Xpert
    Pallas SW; Courey M; Hy C; Killam WP; Warren D; Moore B
    Appl Health Econ Health Policy; 2018 Aug; 16(4):537-548. PubMed ID: 29862440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria.
    Agizew T; Boyd R; Mathebula U; Mathoma A; Basotli J; Serumola C; Pals S; Finlay A; Lekone P; Rankgoane-Pono G; Tlhakanelo T; Chihota V; Auld AF
    PLoS One; 2020; 15(6):e0234646. PubMed ID: 32530972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana's Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early antiretroviral therapy mortality.
    Auld AF; Agizew T; Pals S; Finlay A; Ndwapi N; Boyd R; Alexander H; Mathoma A; Basotli J; Gwebe-Nyirenda S; Shepherd J; Ellerbrock TV; Date A
    BMC Infect Dis; 2016 Oct; 16(1):606. PubMed ID: 27782821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Use of Xpert MTB/Rif for Active Case Finding among TB Contacts in North West Province, South Africa.
    Lebina L; Fuller N; Osoba T; Scott L; Motlhaoleng K; Rakgokong M; Abraham P; Variava E; Martinson NA
    Tuberc Res Treat; 2016; 2016():4282313. PubMed ID: 27493800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed impact of Xpert(®) MTB/RIF on tuberculosis diagnosis in Cambodia.
    Auld SC; Moore BK; Kyle RP; Eng B; Nong K; Pevzner ES; Eam KK; Eang MT; Killam WP
    Public Health Action; 2016 Jun; 6(2):129-35. PubMed ID: 27358807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
    Mavenyengwa RT; Shaduka E; Maposa I
    Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
    PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introducing new tuberculosis diagnostics: the impact of Xpert(®) MTB/RIF testing on case notifications in Nepal.
    Creswell J; Rai B; Wali R; Sudrungrot S; Adhikari LM; Pant R; Pyakurel S; Uranw D; Codlin AJ
    Int J Tuberc Lung Dis; 2015 May; 19(5):545-51. PubMed ID: 25868022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The additional yield of GeneXpert MTB/RIF test in the diagnosis of pulmonary tuberculosis among household contacts of smear positive TB cases.
    Habte D; Melese M; Hiruy N; Gashu Z; Jerene D; Moges F; Yifru S; Girma B; Kassie Y; Haile YK; Suarez PG; Tessema B
    Int J Infect Dis; 2016 Aug; 49():179-84. PubMed ID: 27401584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.
    van Kampen SC; Tursynbayeva A; Koptleuova A; Murzakhmetova Z; Bigalieva L; Aubakirova M; Pak S; van den Hof S
    PLoS One; 2015; 10(7):e0132514. PubMed ID: 26181578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
    BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of tuberculosis from smear-negative presumptive TB cases using Xpert MTB/Rif assay: a cross-sectional study from Nepal.
    Khadka P; Thapaliya J; Basnet RB; Ghimire GR; Amatya J; Rijal BP
    BMC Infect Dis; 2019 Dec; 19(1):1090. PubMed ID: 31888522
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.